We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Eye Implant Stimulates Vision-Restoring Progress

By HospiMedica International staff writers
Posted on 15 Aug 2012
A novel eye implant provides electrical stimulation of the retina that can improve visual perception in blind people with severe to profound retinitis pigmentosa (RP).

The Argus II Retinal Prosthesis System includes an antenna, an electronics case, and an electrode array, and was designed to bypass damaged photoreceptors altogether. More...
The system is based on a video camera set in special glasses that captures a scene. The video is sent to a small patient-worn computer video processing unit (VPU), where it is transformed into excitation instructions sent back to the glasses via a cable. These instructions are then transmitted wirelessly to the antenna in the implant, which passes them to a 60-electrode grid that is surgically implanted and attached to the retina array.

The retina array emits small pulses of electricity that bypass the damaged photoreceptors and stimulate the retina’s remaining cells, which transmit the visual information along the optic nerve to the brain. Patients then learn to interpret these visual patterns, thereby regaining some functional vision. Users of the Argus II bionic eye report that the system helps them perceive rough shapes and track the movement of objects, and that they can slowly read large writing. The result delivers greater independence for patients. The Argus II Retinal Prosthesis System is a product of Second Sight (Sylmar, CA, USA).

“I started to work on retinal implants more than fifteen years ago here in Germany because I knew we could and we should help blind patients suffering from retinitis pigmentosa,” said Prof. Peter Walter, MD, of the Universitäts-Augenklinik RWTH (Aachen, Germany), one of three surgeons in Germany to have implanted Argus II in patients to date. “Today with Argus II, we can finally offer a treatment to patients backed by many years of safety and performance data.”

RP is an inherited, degenerative eye disease that causes severe vision impairment and blindness. A form of retinal dystrophy, RP is caused by abnormalities of the photoreceptors or the retinal pigment epithelium (RPE) of the retina leading to progressive sight loss. Affected individuals may experience defective light to dark or dark to light adaptation, or nyctalopia, as the result of the degeneration of the peripheral visual field (known as tunnel vision). Sometimes, central vision is lost first causing the person to look sidelong at objects.

Related Links:

Second Sight
Universitäts-Augenklinik RWTH



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Vessel Sealing Instrument
ERGOseal
New
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.